Bypassing Immune Rejection in Stem-Cell-Based Therapies – PR Web (press release)
Bypassing Immune Rejection in Stem–Cell-Based TherapiesPR Web (press release)In a recent study published by STEM CELLS, a research group from Stanford University describes a novel regimen for quashing the immunologic barrier with a short-course treatment of two costimlation-adhesion blockade agents, to allow engraftment of …New Stem Cell Treatment Programs at Eterna MDVirtual-Strategy Magazine (press release) … Continue reading